FTC superiority over d4T in phase III trial.
Berger
Daniel S
DS
D017326:Clinical Trials, Phase III as Topic; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018119:Stavudine / Q000009:adverse effects / Q000627:therapeutic use*
D003841:Deoxycytidine; D018119:Stavudine; D000068679:Emtricitabine